1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsHorizon Europe, Cluster 1 (Health) Work Programme - Novel Antiviral Therapeutics, Monoclonal Antibodies, and Innovative Antimicrobials is sponsored by European Commission. This Horizon Europe call supports the development of novel antiviral therapeutics, monoclonal antibodies, and innovative antimicrobials to address pathogens with epidemic potential and drug-resistant infections.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Open to various entities including international consortia. Specific eligibility criteria will be detailed in the call, but international collaboration is encouraged. Confirm the full requirements in the official notice before applying.
Applications for Horizon Europe, Cluster 1 (Health) Work Programme - Novel Antiviral Therapeutics, Monoclonal Antibodies, and Innovative Antimicrobials are due April 13, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Horizon Europe, Cluster 1 (Health) Work Programme - Novel Antiviral Therapeutics, Monoclonal Antibodies, and Innovative Antimicrobials is funded by European Commission. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.